Skip to main content
SpringerLink
Log in

Evaluation of the risk factors for ventricular arrhythmias secondary to QT prolongation induced by papaverine injection during coronary flow reserve studies using a 4 Fr angio-catheter

  • Original Article
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Abstract

Estimation of the fractional flow reserve (FFR) is considered to be an established method by which to assess stable coronary artery stenosis. Induction of maximal coronary hyperemia is important during the FFR procedure. Papaverine has been reported to increase the risk of ventricular arrhythmia (VA). The purpose of the present study was to discover predictors of papaverine-induced VAs developing during FFR measurement. A total of 213 clinically stable patients were included in the study. FFRs were determined after intracoronary papaverine administration (12 mg into the left and 8 mg into the right coronary arteries). We compared patients in whom VA did and did not develop in terms of clinical and electrocardiogram characteristics. FFR measurements were performed on 244 lesions (133 in the left anterior descending arteries, 43 in the left circumflex arteries, and 68 in the right coronary arteries). We found that the QTc interval was prolonged in all patients after papaverine administration (average post-administration QTc interval = 569 ± 89 ms; average ΔQTc interval = 144 ± 80 ms). VA developed in three patients with significantly prolonged QT intervals (average post-administration QTc interval = 639 ± 19 ms, average ΔQTc interval = 220 ± 64 ms, p < 0.02) and transitioned from torsade de pointes to ventricular fibrillation. Bradycardia (< 50 beats/min), hypokalemia (serum K < 3.5 mEp/L), and low left ventricular function (ejection fraction (EF) < 50%) were associated with VA (bradycardia, p < 0.01; hypokalemia, p < 0.01; low left ventricular function, p < 0.01). Three-vessel disease was significantly predictive of VA (p < 0.003). In the three-vessel group, the complications of low left ventricular function, hypokalemia, and bradycardia were significantly associated with VA (p < 0.045). Three-vessel disease is a predictor of the development of VA during FFR measurement performed with the aid of papaverine, especially if accompanied by one or more of the following: low left ventricular function, hypokalemia, or bradycardia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Pijls NH, De Bruyne B, Peels K, Van Der Voort PH, Bonnier HJ, Bartunek J, Koolen JJ, Koolen JJ (1996) Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med 334:1703–1708

    Article  CAS  Google Scholar 

  2. Task Force Members, Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, Bugiardini R, Crea F, Cuisset T, Di Mario C, Ferreira JR, Gersh BJ, Gitt AK, Hulot JS, Marx N, Opie LH, Pfisterer M, Prescott E, Ruschitzka F, Sabaté M, Senior R, Taggart DP, van der Wall EE, ESC Committee for Practice Guidelines, Vrints CJ, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Document Reviewers, Windecker S, Knuuti J, Valgimigli M, Bueno H, Claeys MJ, Donner-Banzhoff N, Erol C, Frank H, Funck-Brentano C, Gaemperli O, Gonzalez-Juanatey JR, Hamilos M, Hasdai D, Husted S, James SK, Kervinen K, Kolh P, Kristensen SD, Lancellotti P, Maggioni AP, Piepoli MF, Pries AR, Romeo F, Rydén L, Simoons ML, Sirnes PA, Steg PG, Timmis A, Wijns W, Windecker S, Yildirir A, Zamorano JL (2013) 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur-Heart J 34(38):2949–3003

    Article  Google Scholar 

  3. Patel MR, Dehmer GJ, Hirshfeld JW, Smith PK, Spertus JA (2012) ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol 59:857–881

    Article  Google Scholar 

  4. De Bruyne B, Fearon WF, Pijls NH, Barbato E, Tonino P, Piroth Z, Jagic N, Mobius-Winckler S, Rioufol G, Witt N, Kala P, MacCarthy P, Engström T, Oldroyd K, Mavromatis K, Manoharan G, Verlee P, Frobert O, Curzen N, Johnson JB, Limacher A, Nüesch E, Jüni P, FAME 2 Trial Investigators (2014) Fractional flow reserve-guided PCI for stable coronary artery disease. N Engl J Med 371:1208–1217

    Article  Google Scholar 

  5. Pijls NH, Fearon WF, Tonino PA, Siebert U, Ikeno F, Bornschein B, van Veer M, Klauss V, Manoharan G, Engstrøm T, Oldroyd KG, Ver Lee PN, MacCarthy PA, De Bruyne B, FAME Study Investigators (2010) Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease : 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation study). J Am Coll Cardiol 56:177–184

    Article  Google Scholar 

  6. Bech GJ, De Bruyne B, Pijls NH, de Muinck ED, Hoorntje JC, Escaned J, Stella PR, Boersma E, Bartunek J, Koolen JJ, Wijns W (2001) Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial. Circulation 103:2928–2934

    Article  CAS  Google Scholar 

  7. van de Hoef TP, Siebes M, Spaan JA, Piek JJ (2015) Fundamentals in clinical coronary physiology: why coronary flow is more important than coronary pressure. Eur Heart J 36:3312–3319

    Article  Google Scholar 

  8. Casella G, Leibig M, Schiele TM, Schrepf R, Seelig V, Stempfle HU, Erdin P, Rieber J, König A, Siebert U, Klauss V (2004) Are high doses of intracoronary adenosine an alternative to standard intravenous adenosine for the assessment of fractional flow reserve? Am Heart J 148:590–595

    Article  CAS  Google Scholar 

  9. De Bruyne B, Pijls NH, Barbato E, Bartunek J, Bech JW, Wijns W, Heyndrickx GR (2003) Intracoronary and intravenous adenosine 5′-triphosphate, papaverine, and contrast medium to assess factional flow reserve in humans. Circulation 107:1877–1883

    Article  Google Scholar 

  10. Nakayama M, Morishima T, Chikamori T, Aiga M, Takazawa K, Yamashina A (2009) Coronary arterial spasm during adenosine myocardial perfusion imaging. J Cardiol 53:288–292

    Article  Google Scholar 

  11. Zahid M, Kapila A, Eagan CE, Yusko DA, Miller ED, Missenda CD (2013) Prevalence and significance of electrocardiographic changes and side effect profile of regadenoson compared with adenosine during myocardial perfusion imaging. J Cardiovasc Dis Res 4:7–10

    Article  Google Scholar 

  12. Nishi T, Kitahara H, Iwata Y, Fujimoto Y, Nakayama T, Takahara M, Sugimoto K, Kobayashi Y (2016) Efficacy of combined administration of intracoronary papaverine plus intravenous adenosine 5′-triphosphate in assessment of fractional flow reserve. J Cardiol 68(6):512–516

    Article  Google Scholar 

  13. Wilson RF, Wyche K, Christensen BV, Zimmer S, Laxson DD (1990) Effects of adenosine on human coronary arterial circulation. Circulation 82:1595–1606

    Article  CAS  Google Scholar 

  14. McGeoch RJ, Oldroyd KG (2008) Pharmacological options for inducing maximal hyperemia during studies of coronary physiology. Catheter Cardiovasc Interv 71:198–204

    Article  Google Scholar 

  15. Kern MJ, Deligonul U, Serota H, Gudipati C, Buckingham T (1990) Ventricular arrhythmia due to intracoronary papaverine: analysis of QT intervals and coronary vasodilatory reserve. Catheter Cardiovasc Diagn 19:229–236

    Article  CAS  Google Scholar 

  16. Inoue T, Asahi S, Takayanagi K, Morooka S, Takabatake Y (1994) QT Prolongation and possibility of ventricular arrhythmias after intracoronary papaverine. Cardiology 84:9–13

    Article  CAS  Google Scholar 

  17. Nakayama M, Tanaka N, Sakoda K, Hokama Y, Hoshino K, Kimura Y, Ogawa M, Yamashita J, Kobori Y, Uchiyama T, Aizawa Y, Yamashina A (2015) Papaverine-induced polymorphic ventricular tachycardia during coronary flow reserve study of patients with moderate coronary artery disease. Circ J 79(3):530–536

    Article  Google Scholar 

  18. Ohkawa S, Imai T, Kubota K, Chida K, Watanabe C, Shimada H, Ohtsubo K, Sugita M (1989) Stenosis lesions and length of the left main coronary artery in the aged. Jpn Heart J 30:770–788

    Article  Google Scholar 

  19. Jain A, Jenkins MG (1989) Intracoronary electrocardiogram during torsade des pointes secondary to intracoronary papaverine. Catheter Cardiovasc Diagn 18:255–257

    Article  CAS  Google Scholar 

  20. Talman CL, Winniford MD, Rossen JD, Simonetti I, Kienzle MG, Marcus ML (1990) Polymorphous ventricular tachycardia: a side effect of intracoronary papaverine. J Am Coll Cardiol 15:275–278

    Article  CAS  Google Scholar 

  21. Vrolix M, Piessens J, Geest HD (1991) Torsades de pointes after intracoronary papaverine. Eur Heart J 12:273–276

    Article  CAS  Google Scholar 

  22. Zhang X, Shen W, Cai X, Zheng A (1993) Polymorphous ventricular tachycardia after intracoronary papaverine: a report of 3 cases. Chin Med Sci J 8:248–249

    CAS  PubMed  Google Scholar 

  23. Goto M, Sato M, Kitazawa H, Takahashi M, Fuse K, Saito A, Okabe M, Aizawa Y (2014) Papaverine-induced QT interval prolongation and ventricular fibrillation in a patient with a history of drug-induced QT prolongation. Intern Med 53:1629–1631

    Article  Google Scholar 

  24. Qian J, Ge J, Baumgart D, Oldenburg O, Haude M, Sack S, Erbel R (2000) Safety of intracoronary Doppler flow measurement. Am Heart J 140:502–510

    Article  CAS  Google Scholar 

  25. Kern MJ, Deligonul U, Serota H, Gudipati C, Buckingham T (1990) Ventricular arrhythmia due to intracoronary papaverine: analysis of QT intervals and coronary vasodilatory reserve. Catheter Cardiovasc Diagn 19:229–236

    Article  CAS  Google Scholar 

  26. Davies JE, Sen S, Dehbi HM, Al-Lamee R, Petraco R, Nijjer SS, Bhindi R, Lehman SJ, Walters D, Sapontis J, Janssens L, Vrints CJ, Khashaba A, Laine M, Van Belle E, Krackhardt F, Bojara W, Going O, Härle T, Indolfi C, Niccoli G, Ribichini F, Tanaka N, Yokoi H, Takashima H, Kikuta Y, Erglis A, Vinhas H, Canas Silva P, Baptista SB, Alghamdi A, Hellig F, Koo BK, Nam CW, Shin ES, Doh JH, Brugaletta S, Alegria-Barrero E, Meuwissen M, Piek JJ, van Royen N, Sezer M, Di Mario C, Gerber RT, Malik IS, Sharp ASP, Talwar S, Tang K, Samady H, Altman J, Seto AH, Singh J, Jeremias A, Matsuo H, Kharbanda RK, Patel MR, Serruys P, Escaned J (2017) Use of the instantaneous wave-free ratio or fractional flow reserve in PCI. N Engl J Med 376:1824–1834

    Article  Google Scholar 

  27. Götberg M, Christiansen EH, Gudmundsdottir IJ, Sandhall L, Danielewicz M, Jakobsen L, Olsson SE, Öhagen P, Olsson H, Omerovic E, Calais F, Lindroos P, Maeng M, Tödt T, Venetsanos D, James SK, Kåregren A, Nilsson M, Carlsson J, Hauer D, Jensen J, Karlsson AC, Panayi G, Erlinge D, Fröbert O, iFR-SWEDEHEART Investigators (2017) Instantaneous wave-free ratio versus fractional flow reserve to guide PCI. N Engl J Med 376:1813–1823

    Article  Google Scholar 

  28. Kim YJ, Hong HK, Lee HS, Moh SH, Park JC, Jo SH, Choe H (2008) Papaverine, a vasodilator, blocks the pore of the HERG channel at submicromolar concentration. J Cardiovasc Pharmacol 52:485–493

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Municipal Tsuruga Hospital, 6-60, 1-chome Mishima cho, Tsuruga, Fukui, Japan

    Kanichi Otowa, Yasuhito Mitamura & Soichiro Usui

  2. Department of Disease Control and Homeostasis, Graduate School of Medical Science, Kanazawa University, 13-1 Takara-machi, Kanazawa, 920-8641, Japan

    Yoshitaka Okabe, Hisayoshi Murai, Shuichi Kaneko & Masayuki Takamura

Authors
  1. Yoshitaka Okabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kanichi Otowa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yasuhito Mitamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hisayoshi Murai
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Soichiro Usui
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Shuichi Kaneko
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Masayuki Takamura
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yoshitaka Okabe.

Ethics declarations

Conflict of interest

The authors state that they have no conflict of interest (COI).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Okabe, Y., Otowa, K., Mitamura, Y. et al. Evaluation of the risk factors for ventricular arrhythmias secondary to QT prolongation induced by papaverine injection during coronary flow reserve studies using a 4 Fr angio-catheter. Heart Vessels 33, 1358–1364 (2018). https://doi.org/10.1007/s00380-018-1175-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00380-018-1175-8

Keywords

Search

Navigation